from FOX News https://ift.tt/3dOZSPG
Regeneron COVID-19 antibody cocktail helps prevent symptomatic disease in study
A monoclonal antibody cocktail developed by Regeneron and Roche dropped the risk of symptomatic COVID-19 by up to 76% after three days for recently infected individuals not yet experiencing symptoms, according to a press release posted Monday.
from FOX News https://ift.tt/3dOZSPG
from FOX News https://ift.tt/3dOZSPG
Related Posts:
LIVE UPDATES: CDC panel to meet Tuesday on coronavirus vaccine distribution- US hits record-high coronavirus hospitalizations, data shows
- CDC panel to meet Tuesday to vote on COVID-19 vaccine priority
- United Airlines flying Pfizer COVID-19 vaccine
- Dr. Siegel: COVID-19 vaccine side effects are 'transient' compared to severe virus symptoms
0 comments:
Post a Comment